AB0405 Safety of rituximab therapy in autoimmune diseases:systematic review and meta-analysis

K Kobayashi; KM Minegishi; N Horita; S Ohno; HN Nakajima

doi:10.1136/annrheumdis-2017-eular.5643

Article info

PDF

Abstracts Accepted for Publication

Rheumatoid arthritis - other biologic treatment

AB0405 Safety of rituximab therapy in autoimmune diseases:systematic review and meta-analysis

Free

Authors

K Kobayashi 1Center for Rheumatic Diseases, Yokohama City University Medical Center PubMed articles Google scholar articles
KM Minegishi 1Center for Rheumatic Diseases, Yokohama City University Medical Center PubMed articles Google scholar articles
N Horita 2Department of Pulmonology PubMed articles Google scholar articles
S Ohno 1Center for Rheumatic Diseases, Yokohama City University Medical Center PubMed articles Google scholar articles
HN Nakajima 3Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan PubMed articles Google scholar articles

Citation

Kobayashi K, Minegishi K, Horita N, et al

AB0405 Safety of rituximab therapy in autoimmune diseases:systematic review and meta-analysis

Annals of the Rheumatic Diseases 2017;76:1191.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password